OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the IL ‐5 pathway in eosinophilic asthma: A comparison of anti‐IL ‐5 versus anti‐IL ‐5 receptor agents
David J. Jackson, Michael E. Wechsler, Guy Brusselle, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 2943-2952
Open Access | Times Cited: 7
David J. Jackson, Michael E. Wechsler, Guy Brusselle, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 2943-2952
Open Access | Times Cited: 7
Showing 7 citing articles:
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Translational approaches to the study of eosinophils in vasculitis
Allyson Egan, Paneez Khoury
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i19-i23
Closed Access
Allyson Egan, Paneez Khoury
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i19-i23
Closed Access
The role of the NLRP3 inflammasome in the pathogenesis of asthma: inflammatory mechanisms and emerging therapeutic strategies
И. Х. Борукаева, Kemran G. Edilov, Alina S. Dzueva, et al.
Kazan medical journal (2025)
Open Access
И. Х. Борукаева, Kemran G. Edilov, Alina S. Dzueva, et al.
Kazan medical journal (2025)
Open Access
Head‐To‐Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
Brian J. Lipworth, Robert Greig, Rory Chan, et al.
Allergy (2025)
Open Access
Brian J. Lipworth, Robert Greig, Rory Chan, et al.
Allergy (2025)
Open Access
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
Mayu Shiomi, Ryu Watanabe, Ryuhei Ishihara, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 544-544
Open Access
Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps
Joaquim Mullol, Maria D’Amato, Eugenio De Corso, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 4
Open Access
Joaquim Mullol, Maria D’Amato, Eugenio De Corso, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 4
Open Access
Challenges and Opportunities in Achieving Asthma Remission
Elena Cojocaru, Raluca Ioana Arcana, Steluţa Radu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2835-2835
Open Access
Elena Cojocaru, Raluca Ioana Arcana, Steluţa Radu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2835-2835
Open Access
